Take me to ISPE homepage
Search Options
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Skip main navigation (Press Enter).
Toggle navigation
Search Options
Communities
All Communities
My Communities
Directory
Browse
Discussion Posts
Library Entries
Participate
Help/FAQs
Engage in Mentoring
Specific Treatment-outcome association studies of COVID-19
When:
Dec 1, 2020 from 09:00 to 10:00 (ET)
Moderators:
Ann McMahon and Montse Soriano-Gabarro
Clinical Outcomes From COVID-19 Following Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers Among Patients with Hypertension in South Korea: A nationwide study.
Ju Hwan Kim,
Sungkyunkwan University, Suwon, Korea, Republic of
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lars Christian Lund,
University of Southern Denmark, Odense, Denmark
Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study.
Sascha Dublin,
Kaiser Permanente Washington Health Research Institute, Seattle, USA, Department of Epidemiology, University of Washington, Seattle, USA
Inhaled corticosteroid use and risk of COVID-19 related death among 967,047 patients with COPD or asthma: an OpenSAFELY analysis
Anna Schultze,
London School of Hygiene and Tropical Medicine, London, United Kingdom
Location
Online Instructions:
Url:
http://register.gotowebinar.com/register/8612124246515415052
Login:
Download to Your Calendar
Powered by Higher Logic